Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Nerves and chemicals in the body can affect hair growth and loss.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Fibroblasts can be turned into melanocytes for potential skin treatments.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Prolactin slows down hair growth in mice.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

The hydrogel effectively treats infected burn wounds by reducing pain and preventing infection.

Prolactin may affect hair growth differently based on gender and scalp area.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Skin organoids are a promising new model for studying human skin development and testing treatments.